Elev8 Venture Partners, a newly established Indian growth-stage investor, has launched its debut fund with a target of USD 200m.
“This will also be India's first pro rata fund which will partner with leading seed funds and super angels to invest in winners of their portfolio companies,” Navin Honagudi, co-founder and general...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.